EARNEST Partners’s ResMed RMD Stock Holding History

EARNEST Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-61	Closed	-$9.02K	–	929
2023 Q3	$9.02K	Hold	61	–	–	﹤0.01%	668
2023 Q2	$13.3K	Hold	61	–	–	﹤0.01%	567
2023 Q1	$13.4K	Hold	61	–	–	﹤0.01%	561
2022 Q4	$12.7K	Hold	61	–	–	﹤0.01%	569
2022 Q3	$13K	Hold	61	–	–	﹤0.01%	536
2022 Q2	$13K	Hold	61	–	–	﹤0.01%	545
2022 Q1	$15K	Hold	61	–	–	﹤0.01%	556
2021 Q4	$16K	Hold	61	–	–	﹤0.01%	560
2021 Q3	$16K	Hold	61	–	–	﹤0.01%	542
2021 Q2	$15K	Hold	61	–	–	﹤0.01%	553
2021 Q1	$12K	Hold	61	–	–	﹤0.01%	591
2020 Q4	$13K	Hold	61	–	–	﹤0.01%	553
2020 Q3	$10K	Hold	61	–	–	﹤0.01%	573
2020 Q2	$12K	Hold	61	–	–	﹤0.01%	522
2020 Q1	$9K	Hold	61	–	–	﹤0.01%	541
2019 Q4	$9K	Hold	61	–	–	﹤0.01%	619
2019 Q3	$8K	Hold	61	–	–	﹤0.01%	629
2019 Q2	$7K	Hold	61	–	–	﹤0.01%	672
2019 Q1	$6K	Hold	61	–	–	﹤0.01%	701
2018 Q4	$7K	Hold	61	–	–	﹤0.01%	630
2018 Q3	$7K	Hold	61	–	–	﹤0.01%	678
2018 Q2	$6K	Hold	61	–	–	﹤0.01%	714
2018 Q1	$6K	Hold	61	–	–	﹤0.01%	699
2017 Q4	$5K	Buy	+61	New	+$5.04K	﹤0.01%	758
2017 Q1	–	Sell	-61	Closed	-$4K	–	766
2016 Q4	$4K	Buy	+61	New	+$3.74K	﹤0.01%	760

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EARNEST Partners's RMD Position: Q4 2023 in Review

EARNEST Partners sold out of ResMed (RMD) in Q4 2023, closing a stake of 61 shares — an estimated $9.02K sold.

EARNEST Partners first reported a position in RMD in Q4 2016 and held it in 25 quarters. The position peaked at $16K in Q4 2021. 688 funds tracked by Wall St. Rank hold RMD as of Q4 2023.

EARNEST Partners reported no remaining ResMed position as of Q4 2023 after selling out during the quarter.
EARNEST Partners sold 61 ResMed shares in Q4 2023, an estimated $9.02K.
EARNEST Partners first reported a position in ResMed in Q4 2016 and held it in 25 quarters.
EARNEST Partners's ResMed position peaked at $16K in Q4 2021.
688 funds tracked by Wall St. Rank held ResMed as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.